What happened at the NAMS 2022 Annual Meeting?

Newly published data from a phase 3 study demonstrate the safety and efficacy of fezolinetant (Astellas) for treatment of VMS due to menopause.

In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.

At the International Society for the Study of Women’s Sexual Health (ISSWSH) conference, held this year March 2 to 5 in St. Louis, Missouri, Contemporary OB/GYN®’s digital editor, Michael Krychman, MD, spoke with Ashley Tapscott, a board-certified urologist trained in male and female sexual dysfunction, who works in Charlotte, North Carolina.

In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

A new study suggests that ospemifene can reduce harmful bacteria and significantly contribute to vaginal health in postmenopausal women.

A new study offers insights into future guidelines for certain populations of pregnant women during a national pandemic.